These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 21804392)
21. A case of ovarian endometrioid adenocarcinoma with a yolk sac tumor component. Abe A; Furumoto H; Yoshida K; Nishimura M; Irahara M; Kudo E; Sano T Int J Gynecol Cancer; 2008; 18(1):168-72. PubMed ID: 17466041 [TBL] [Abstract][Full Text] [Related]
22. Gonadoblastoma and hepatoid and endometrioid-like yolk sac tumor: an update. Ulbright TM Int J Gynecol Pathol; 2014 Jul; 33(4):365-73. PubMed ID: 24901396 [TBL] [Abstract][Full Text] [Related]
23. Proliferative activity and p53 over-expression of ovarian epithelial tumors. Kuwata T; Kitagawa M; Takemura T; Hirokawa K Gen Diagn Pathol; 1995 Oct; 141(2):131-9. PubMed ID: 8548593 [TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Sugiyama T; Kamura T; Kigawa J; Terakawa N; Kikuchi Y; Kita T; Suzuki M; Sato I; Taguchi K Cancer; 2000 Jun; 88(11):2584-9. PubMed ID: 10861437 [TBL] [Abstract][Full Text] [Related]
25. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger. Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706 [TBL] [Abstract][Full Text] [Related]
27. Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm. Analysis of six cases. Nogales FF; Bergeron C; Carvia RE; Alvaro T; Fulwood HR Am J Surg Pathol; 1996 Sep; 20(9):1056-66. PubMed ID: 8764742 [TBL] [Abstract][Full Text] [Related]
28. [Assessment of prognostic factors in common ovarian tumors of varying malignancy]. Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877 [TBL] [Abstract][Full Text] [Related]
29. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas]. Shao HL; Shen DH; Xue WC; Li Y; Yu YZ Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760 [TBL] [Abstract][Full Text] [Related]
30. Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma. Cheng L; Zhang S; Talerman A; Roth LM Hum Pathol; 2010 May; 41(5):716-23. PubMed ID: 20096442 [TBL] [Abstract][Full Text] [Related]
31. Endometrioid epithelial ovarian cancer : 20 years of prospectively collected data from a single center. Storey DJ; Rush R; Stewart M; Rye T; Al-Nafussi A; Williams AR; Smyth JF; Gabra H Cancer; 2008 May; 112(10):2211-20. PubMed ID: 18344211 [TBL] [Abstract][Full Text] [Related]
32. Hepatoid malignancy of unknown origin--a diagnostic conundrum: review of literature and case report of collision with adenocarcinoma. Gopaldas R; Kunasani R; Plymyer MR; Bloch RS Surg Oncol; 2005 Jul; 14(1):11-25. PubMed ID: 15777886 [TBL] [Abstract][Full Text] [Related]
33. Ovarian yolk sac tumor in postmenopausal females: A case series and a literature review. Wang Y; Yang J; Yu M; Cao D; Zhang Y; Zong X; Shen K Medicine (Baltimore); 2018 Aug; 97(33):e11838. PubMed ID: 30113473 [TBL] [Abstract][Full Text] [Related]
34. Ovarian malignant mixed germ cell tumor with clear cell carcinoma in a postmenopausal woman. Yu XJ; Zhang L; Liu ZP; Shi YQ; Liu YX Int J Clin Exp Pathol; 2014; 7(12):8996-9001. PubMed ID: 25674278 [TBL] [Abstract][Full Text] [Related]
35. Ovarian endometrioid carcinoma with yolk sac tumor component in a postmenopausal woman. Kabukcuoglu S; Arik D Eur J Gynaecol Oncol; 2016; 37(6):867-869. PubMed ID: 29943939 [TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors. Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351 [TBL] [Abstract][Full Text] [Related]
37. [Analysis of serum CA125, CEA, AFP, LDH levels and LDH isoenzymes in patients with ovarian tumors--correlation between tumor markers and histological types of ovarian tumors]. Konishi I; Fujii S; Okamura H; Sakahara H; Endo K; Torizuka K; Suzuki A; Mori T Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):827-36. PubMed ID: 2426374 [TBL] [Abstract][Full Text] [Related]
38. Minor serous and clear cell components adversely affect prognosis in ''mixed-type'' endometrial carcinomas: a clinicopathologic study of 36 stage-I cases. Quddus MR; Sung CJ; Zhang C; Lawrence WD Reprod Sci; 2010 Jul; 17(7):673-8. PubMed ID: 20393071 [TBL] [Abstract][Full Text] [Related]
39. The pluripotential nature of the mesenchyme-like component of yolk sac tumor. Michael H; Ulbright TM; Brodhecker CA Arch Pathol Lab Med; 1989 Oct; 113(10):1115-9. PubMed ID: 2478105 [TBL] [Abstract][Full Text] [Related]
40. Human ovarian tumors express gamma-glutamyl transpeptidase. Hanigan MH; Frierson HF; Brown JE; Lovell MA; Taylor PT Cancer Res; 1994 Jan; 54(1):286-90. PubMed ID: 7903206 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]